Suggested Topics within your search.
Showing 681 - 700 results of 1,973 for search '"antigen"', query time: 0.05s Refine Results
  1. 681

    Extra-ocular sebaceous carcinoma - A rare case report by Manda Sindhura, Tummidi Santosh, Jarang Rajesh Kumar, Arundhathi Shankaralingappa, Naresh Kumar Pannerselvam, Pavithra Balakrishna

    Published 2023-01-01
    “…Immunohistochemistry was positive for epithelial membrane antigen. Sebaceous carcinoma accounts for 0.2–4.6% of all malignant cutaneous neoplasms, and the estimated rate of occurrence is only 1–2 per 1 million individuals per year. …”
    Get full text
    Article
  2. 682

    The Impact of the Myeloid Response to Radiation Therapy by Michael J. Gough, Kristina Young, Marka Crittenden

    Published 2013-01-01
    “…As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby assisting multiple critical checkpoints in antitumor adaptive immunity. …”
    Get full text
    Article
  3. 683

    New Concepts in the Diagnosis and Pathogenesis of Trichomonas vaginalis by Renuka Bhatt, Mary Abraham, Dino Petrin, Gary E Garber

    Published 1996-01-01
    “…The application of monoclonal antibodies, either singly or in a group that recognizes a common antigen, along with methods such as detection of common DNA fragment from clinical specimens, may have a promising future in the laboratory diagnosis of trichomoniasis.…”
    Get full text
    Article
  4. 684

    A Survey of Artificial Immune System Based Intrusion Detection by Hua Yang, Tao Li, Xinlei Hu, Feng Wang, Yang Zou

    Published 2014-01-01
    “…This framework is analyzed and discussed based on three core aspects: antibody/antigen encoding, generation algorithm, and evolution mode. …”
    Get full text
    Article
  5. 685

    Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report by O. P. Arewa, S. Nahirniak, G. Clarke

    Published 2013-01-01
    “…PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. …”
    Get full text
    Article
  6. 686

    Some Basic Aspects of HLA-G Biology by Estibaliz Alegre, Roberta Rizzo, Daria Bortolotti, Sara Fernandez-Landázuri, Enrico Fainardi, Alvaro González

    Published 2014-01-01
    “…Human leukocyte antigen-G (HLA-G) is a low polymorphic nonclassical HLA-I molecule restrictively expressed and with suppressive functions. …”
    Get full text
    Article
  7. 687

    Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets by Sanya Arshad, Benjamin Cameron, Alok V. Joglekar

    Published 2025-01-01
    “…Abstract T cells mediate pathogenesis of several autoimmune disorders by recognizing self-epitopes presented on Major Histocompatibility Complex (MHC) or Human Leukocyte Antigen (HLA) complex. The majority of autoantigens presented to T cells in various autoimmune disorders are not known, which has impeded autoantigen identification. …”
    Get full text
    Article
  8. 688

    Induction of Immunological Tolerance by Oral Anti-CD3 by Andre Pires da Cunha, Howard L. Weiner

    Published 2012-01-01
    “…Oral tolerance is of unique immunologic importance because it is a continuous natural immunologic event driven by exogenous antigen and is an attractive approach for treatment of these conditions. …”
    Get full text
    Article
  9. 689

    Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies by Shangjun Sun, He Hao, Ge Yang, Yi Zhang, Yang Fu

    Published 2018-01-01
    “…T cells modified via chimeric antigen receptors (CARs) have emerged as a promising treatment modality. …”
    Get full text
    Article
  10. 690

    The laboratory diagnosis of Chlamydia trachomatis infections by Max A Chernesky

    Published 2005-01-01
    “…Most invasive specimens, such as cervical or urethral swabs, may be collected for culture, antigen or nucleic acid detection. Noninvasive samples such as first-void urine and vaginal swabs can be easily collected by the patient; these samples must be tested by more sensitive nucleic acid amplification tests. …”
    Get full text
    Article
  11. 691

    Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus? by Joshua Juwono, Ryan D. Martinus

    Published 2016-01-01
    “…We will examine the links between Hsp60 and cellular anti- and proinflammatory processes and specifically address how Hsp60 appears to affect immune inflammation by at least two different mechanisms: as a ligand for innate immune receptors and as an antigen recognised by adaptive immune receptors. We will also look at the role of Hsp60 during immune cell activation in atherosclerosis, a significant risk factor during the pathogenesis of diabetes mellitus.…”
    Get full text
    Article
  12. 692

    Potential Human Models of Infammatory Bowel Disease by Stephen B Hanauer

    Published 1995-01-01
    “…Alternative natural history or interventional studies in patients with human leukocyte antigen (HLA)-B27 spondylarthropathy may be useful. …”
    Get full text
    Article
  13. 693

    The Child as a Surrogate for Diagnosis of Lupus in the Mother by Olufemi O. Adelowo, Kenneth A. Ohagwu, Ejiehi E. Aigbokhan, Richard O. Akintayo

    Published 2017-01-01
    “…The baby was positive for ANA, extractable nuclear antigen (ENA), and anti-Ro/SSA. Pediatric echocardiography was abnormal and electrocardiography confirmed complete heart block.…”
    Get full text
    Article
  14. 694

    (1 →3)- β -D-Glucan and endotoxin modulate immune response to inhaled allergen by R. Rylander, P. G. Holt

    Published 1998-01-01
    “…To study the effects of such a coexposure, the humoral and inflammatory responses were studied in guinea pigs inhaling the T-cell dependent antigen ovalbumin (OVA) and the inflammatory agents (1→3)-β -D-glucan and lipopolysaccharide (LPS). …”
    Get full text
    Article
  15. 695

    Modeling shrimp biomass and viral infection for production of biological countermeasures by H. Thomas Banks, V. A. Bokil, Shuhua Hu, A. K. Dhar, R. A. Bullis, C. L. Browdy, F.C.T. Allnutt

    Published 2006-07-01
    “…Wecouple equations for biomass production with those for vaccine production inshrimp that have been infected with a recombinant viral vector expressing aforeign antigen. The model system entails both size and class-age structure.…”
    Get full text
    Article
  16. 696

    A Chemical Synthesis of Benzo[a]pyrene Hapten and Its Application in a Streptavidin-Horseradish Peroxidase-Based Enzyme-Linked Immunological Analysis by Zhen Ma, Huisheng Zhuang

    Published 2018-01-01
    “…A specific BaP hapten was synthesized and BaP antigens (immunogen, coating antigen) were prepared using diverse methods. …”
    Get full text
    Article
  17. 697
  18. 698

    Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer by Kevin S. Choe, Stanley L. Liauw

    Published 2010-01-01
    “…Since the introduction of screening with prostate-specific antigen (PSA), most patients are being diagnosed at an early stage with low-risk disease. …”
    Get full text
    Article
  19. 699

    Approach to Pregnancy Affected by Kell Alloimmunization by Serdar Aykut, Suleyman Cansun Demir, Ismaıl Cuneyt Evruke, Mete Sucu, Fatma Islek Uzay, Mesut Avan, Ozge Keles Bayer, Emre Yalcin

    Published 2024-01-01
    “…K (KEL1) from the Kell blood group system is the most potent immunogenic antigen after D among all blood group antigens. K-HDFN occurs in 0.1–0.3% of pregnant women. …”
    Get full text
    Article
  20. 700

    CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS by Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

    Published 2024-01-01
    “…The treatment of follicular lymphoma patients with multiply relapsed or refractory disease represents an area of high-unmet needing new treatments with stronger efficacy. Chimeric antigen receptor (CAR)-T cell therapy targeting B-cell antigens, such as CD19 or CD20, is emerging as an efficacious treatment for R/R follicular lymphoma patients, particularly for those with early relapse and refractory to alkylating agents and to anti-CD20 monoclonal antibodies, resulting in a high rate of durable responses in a high proportion of patients.   …”
    Get full text
    Article